Sarepta Therapeutics suffered another major setback on Friday as Europe's drug regulator decided not to recommend the ...

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are ...

Separately, Sareptea said last week that it would pause the development of most of its experimental gene therapies for a different type of muscular dystrophy. The stoppage came after one of the ...

Sarepta Therapeutics' brutal week continued Friday after European officials rejected the company's controversial gene therapy ...

European regulators said that a Duchenne gene therapy should not be approved, imperiling the treatment that is also facing ...

Roche Holding AG’s gene therapy Elevidys failed to get the backing of European regulators.The European Medicines Agency’s drug advisory committee recommended against Elevidys for children with ...

Wall Street is ending the week on a positive note, with stocks hitting fresh all-time highs amid a solid earnings season and ...

Wall Street is ending the week on a quiet note, with stocks hovering near their all-time highs as traders digest the latest ...